IGC PHARMA, INC. (IGC) Free cash flow 2016–2025
IGC PHARMA, INC. (IGC) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$4.9MFY2025 · since FY2016: -$279,887 → -$4.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.9M | +8.1% |
| FY2024 | -$5.3M | +27.5% |
| FY2023 | -$7.4M | +4.4% |
| FY2022 | -$7.7M | +37.3% |
| FY2021 | -$12.3M | +6.1% |
| FY2020 | -$13.1M | -290.6% |
| FY2019 | -$3.3M | -61.8% |
| FY2018 | -$2.1M | -34.5% |
| FY2017 | -$1.5M | -449.1% |
| FY2016 | -$279,887 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice